Posts

Showing posts from December, 2021

The Exploitation of the #BossBabe: Multi-level Marketing Schemes and Gender Roles

          The Exploitation of the #BossBabe: Multi-level Marketing Schemes and Gender Roles               Dayna Wilson – 300113188 SOCI 1125 – 005: Introduction to Sociology Dr. Siobhan Ashe Douglas College 13 December, 2021 Word Count: 1431       When the multi-level marketing (MLM) scheme was initially ideated in the 1930s with Avon (then California Perfume Company), it afforded women the opportunity to make money independently of the allowances designated to them by their husbands, as was the norm at the time. This allowed women to gain a modicum of freedom previously unrealized and opened doors of female empowerment. A century later, however, the model and its outcomes have undoubtedly shifted. MLMs, which are characterized by person-to-person sales and the recruitment of fellow distributors, tend to disproportionately target women and exploit gender inequality. This frequently leads to the further marginalization of an already vulnerable p

No State Left Behind: The Necessity of Prioritizing Low-Income Countries in COVID-19 Recovery

                    No State Left Behind: The Necessity of Prioritizing Low-Income Countries in COVID-19 Recovery                 Dayna Wilson – 300113188 8 December, 2021 Introduction to World Politics POLI 1103 – 050 Douglas College Dr. Stewart Prest Word Count: 1140       When the first COVID-19 vaccines became available in December of 2020, many breathed a sigh of relief. While there was no doubt that the pandemic and resulting economic strife were far from over, the development of a vaccine was seen as a concrete first step towards recovery from the virus that had been afflicting the globe since March of that year. And indeed, another year on, much is returning to some version of normal for the wealthier countries fortunate enough to have had unfettered access to vaccines. Those living in low-income countries have not been so lucky, however, with only 5.8% of individuals having received a first dose of a vaccine compared to